Rigid fusions of designed helical repeat binding proteins efficiently protect a binding surface from crystal contacts.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 11 2019
Historique:
received: 17 07 2019
accepted: 09 10 2019
entrez: 9 11 2019
pubmed: 9 11 2019
medline: 28 10 2020
Statut: epublish

Résumé

Designed armadillo repeat proteins (dArmRPs) bind extended peptides in a modular way. The consensus version recognises alternating arginines and lysines, with one dipeptide per repeat. For generating new binding specificities, the rapid and robust analysis by crystallography is key. Yet, we have previously found that crystal contacts can strongly influence this analysis, by displacing the peptide and potentially distorting the overall geometry of the scaffold. Therefore, we now used protein design to minimise these effects and expand the previously described concept of shared helices to rigidly connect dArmRPs and designed ankyrin repeat proteins (DARPins), which serve as a crystallisation chaperone. To shield the peptide-binding surface from crystal contacts, we rigidly fused two DARPins to the N- and C-terminal repeat of the dArmRP and linked the two DARPins by a disulfide bond. In this ring-like structure, peptide binding, on the inside of the ring, is very regular and undistorted, highlighting the truly modular binding mode. Thus, protein design was utilised to construct a well crystallising scaffold that prevents interference from crystal contacts with peptide binding and maintains the equilibrium structure of the dArmRP. Rigid DARPin-dArmRPs fusions will also be useful when chimeric binding proteins with predefined geometries are required.

Identifiants

pubmed: 31700118
doi: 10.1038/s41598-019-52121-9
pii: 10.1038/s41598-019-52121-9
pmc: PMC6838082
doi:

Substances chimiques

Armadillo Domain Proteins 0
Carrier Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16162

Références

Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Protein Sci. 2017 Oct;26(10):1942-1952
pubmed: 28691351
Protein Sci. 2012 Jul;21(7):1015-28
pubmed: 22544642
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Nat Biotechnol. 2004 May;22(5):575-82
pubmed: 15097997
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Science. 2012 May 25;336(6084):1030-3
pubmed: 22628654
Bioconjug Chem. 2012 Feb 15;23(2):279-86
pubmed: 22188139
Protein Sci. 2017 Sep;26(9):1796-1806
pubmed: 28639341
J Mol Biol. 2012 Nov 23;424(1-2):68-87
pubmed: 22985964
J Struct Biol. 2014 Feb;185(2):147-62
pubmed: 23916513
Biol Chem. 2017 Jan 1;398(1):23-29
pubmed: 27636831
J Mol Biol. 2016 Apr 24;428(8):1574-88
pubmed: 26975886
Protein Sci. 2014 Nov;23(11):1572-83
pubmed: 25132085
J Mol Biol. 2008 Mar 7;376(5):1282-304
pubmed: 18222472
J Mol Biol. 2019 May 3;431(10):2020-2039
pubmed: 30930049
Methods Enzymol. 2011;487:545-74
pubmed: 21187238
Protein Cell. 2018 Jan;9(1):3-14
pubmed: 28271446
Sci Rep. 2017 Sep 11;7(1):11217
pubmed: 28894181
Acta Crystallogr D Struct Biol. 2016 Jan;72(Pt 1):168-75
pubmed: 26894544
Cell. 1998 Jul 24;94(2):193-204
pubmed: 9695948
Annu Rev Pharmacol Toxicol. 2015;55:489-511
pubmed: 25562645
Nat Commun. 2016 Jun 03;7:11672
pubmed: 27255951
J Mol Biol. 2003 Sep 12;332(2):489-503
pubmed: 12948497
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Struct Biol. 2018 Feb;201(2):108-117
pubmed: 28864298
ACS Synth Biol. 2018 Sep 21;7(9):2226-2235
pubmed: 30148951
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
J Am Chem Soc. 2016 Mar 16;138(10):3526-32
pubmed: 26878586
Curr Opin Struct Biol. 2014 Aug;27:102-12
pubmed: 25033247
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Structure. 2000 Mar 15;8(3):329-38
pubmed: 10745017
Protein Sci. 2012 Sep;21(9):1298-314
pubmed: 22767482
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):484-96
pubmed: 22505269
Cell. 2001 May 4;105(3):391-402
pubmed: 11348595

Auteurs

Patrick Ernst (P)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.

Annemarie Honegger (A)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.

Floor van der Valk (F)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.

Christina Ewald (C)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Cytometry Facility, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.

Peer R E Mittl (PRE)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.

Andreas Plückthun (A)

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland. plueckthun@bioc.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH